Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02994979 · ClinicalTrials.gov registry record · NA

Nursing Assistant Intervention to Prevent Delirium in Nursing Homes

A NA study of Delirium, sponsored by Jewish Home & Hospital Lifecare System.

Completed
Registry status
NA
Development phase
219
Enrollment target
1
Study location

NCT02994979 is a NA study of Delirium that has completed, run by Jewish Home & Hospital Lifecare System. The registered enrollment target is 219 participants, below the 884-participant average among 62 other Delirium trials with a reported enrollment target (75% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02994979, a NA study of Delirium, has completed, sponsored by Jewish Home & Hospital Lifecare System.

COMPLETED
Registry status
NA
Development phase
219 participants
Enrollment target
1
Study location

Study Summary

Delirium is an acute confusion that occurs in one third of hospitalized older adults. As compared to those without delirium, hospitalized patients with delirium have longer hospital stays, higher mortality, and increased risk of nursing home utilization. Substantial attention has been paid to developing, testing, and disseminating interventions to prevent delirium in the hospital but, to date, not in the nursing home setting. In a previous study we used known information on delirium risk factors to develop an intervention that can be delivered at onset of acute illness in nursing home patients. The current study is designed to test the effect of this intervention in a single-site clinical trial. Objectives: 1) to determine, as compared to control, the effect of a multicomponent intervention targeting delirium risk factors on delirium frequency, delirium severity, cognitive and physical function decline, and hospitalization in nursing home patients with acute illness, and 2) to identify features of the intervention associated with occurrence of delirium and other outcomes. Approach: We will screen nursing home patients on 17 long-term care units at a large, urban nursing home who experience onset of a change in condition according to established criteria, and enroll and assign them to intervention or control in a 1:1 ratio. Those assigned to intervention will receive daily visits from an Elder Life Specialist, a mobile Certified Nursing Assistant trained to provide services to counter risks for delirium, including dehydration, immobility, cognitive impairment, undernutrition, and sleep problems, for the duration of the acute illness and for 1 week following. Patients assigned to control will receive usual care from the unit-based nurses and the patient's primary team. Delirium will be assessed 5 days a week by a research assistant. Cognitive and physical function decline and hospital transfer will be ascertained during a 1 month follow-up period. We will compare outc

Conditions Studied

Interventions

  • OTHER Sham comparator
  • OTHER Delirium-prevention

Study Locations (1)

New York

  • The New Jewish Home - New York

Trial Details

FieldValue
Enrollment Target 219 participants
Start Date 2016-11
Est. Completion 2018-08-28
Phase NA

What the Registry Record Tells You About NCT02994979

The ClinicalTrials.gov registry entry for NCT02994979 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 219 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 884-participant average among 62 other Delirium trials with a reported enrollment target (75% lower). The listed sponsor is Jewish Home & Hospital Lifecare System, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Delirium appearing as the primary indexed condition, and to 2 interventions - of which Sham comparator is the first listed.

NCT02994979 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT02994979 about?

NCT02994979 is a clinical study titled "Nursing Assistant Intervention to Prevent Delirium in Nursing Homes". Delirium is an acute confusion that occurs in one third of hospitalized older adults. As compared to those without delirium, hospitalized patients with delirium have longer hospital stays, higher mortality, and increased risk of nursing home utilization. Substantial attention has been paid to develo...

What is the current status of trial NCT02994979?

This trial is currently completed. It is a NA study. The enrollment target is 219 participants. The study started on 2016-11. Estimated completion is 2018-08-28.

What conditions does trial NCT02994979 study?

This clinical trial studies the following conditions: Delirium.

What interventions are being tested in trial NCT02994979?

The interventions under investigation include: Sham comparator (OTHER), Delirium-prevention (OTHER).

Who is sponsoring clinical trial NCT02994979?

This trial is sponsored by Jewish Home & Hospital Lifecare System, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02994979 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Delirium

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.